TPD54 Downregulates ERK Signaling in Oral Squamous Cell Carcinoma Cells

A CD109-SMURF2 Axis Diverts EGFR from Degradation to Sustain Oncogenic Signaling and Promote Squamous Cell Carcinoma Invasion and Stemness
T. Kungyal, A. Hassan, K. Finnson +2
bioRxiv2 Sep 2026PreprintAll rights reservedFull textOncologybioRxiv
Prognostic value of the Hippo signaling pathway in oral squamous cell carcinoma: a systematic review and meta-analysis
I. Lima, L. d. S. Bittencourt, P. G. Reinehr +2
medRxiv9 Oct 2026PreprintAll rights reservedFull textOncologymedRxiv
Role of podoplanin in tongue squamous cell carcinoma and the regulation of malignant cellular behaviors via the ERK/MMP-2 signaling axis
Xiaowei Sheng, Liping Ding, Qiang Zhang +2
Translational cancer research20 Sep 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
Acetaldehyde Dehydrogenase 2 Remodels the Tumor Immune Microenvironment via CXCR4-CXCL12 Signaling in Head and Neck Squamous Cell Carcinoma
Taowei Wu, Faya Liang, Ying Li +5
Journal of Biological Chemistry1 Oct 2026Peer-reviewedCC BY 4.0OncologyCrossref
Association of NCCRP1 expression with T category and in vitro growth-related characteristics of head and neck squamous cell carcinoma FaDu cells
Hanako Koda, Teruki Hagiwara, Kazuhiko Yamada +3
Global Health & Medicine31 Oct 2026Peer-reviewedLicence not statedFull textGeneral medicinePMC

Cite

BibTeX

@article{anon2026tpd54,
  title = {{TPD54 Downregulates ERK Signaling in Oral Squamous Cell Carcinoma Cells}},
  journal = {Biomedicines},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13701923},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - TPD54 Downregulates ERK Signaling in Oral Squamous Cell Carcinoma Cells
PY  - 2026
DA  - 2026/10/01
JO  - Biomedicines
UR  - https://europepmc.org/article/PMC/PMC13701923
SN  - 2227-9059
ER  -

Related

Cite